Canature Health Technology Co., Ltd. (SHE:300272)
China · Delayed Price · Currency is CNY 5.74
+0.09 (1.59%)
Jun 12, 2026, 3:04 PM CST
SHE:300272 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,510 | 4,574 | 3,475 | 3,483 | 2,949 | 4,078 | |
Market Cap Growth | 0.18% | 31.61% | -0.21% | 18.08% | -27.68% | 38.34% |
Enterprise Value | 3,927 | 4,601 | 3,639 | 3,464 | 3,090 | 4,321 |
Last Close Price | 5.74 | 7.48 | 6.00 | 5.76 | 4.75 | 6.44 |
PE Ratio | 35.98 | 81.66 | 41.58 | 26.29 | 31.86 | 38.89 |
Forward PE | - | 27.50 | 27.50 | 27.50 | 27.50 | 27.50 |
PS Ratio | 1.91 | 2.48 | 2.06 | 2.08 | 1.78 | 2.70 |
PB Ratio | 2.57 | 3.35 | 2.65 | 2.54 | 2.64 | 3.26 |
P/TBV Ratio | 3.50 | 4.56 | 3.53 | 3.32 | 3.64 | 4.55 |
P/FCF Ratio | 22.66 | 29.53 | 18.29 | 11.82 | 48.47 | 35.31 |
P/OCF Ratio | 11.71 | 15.27 | 12.00 | 9.29 | 18.98 | 21.83 |
EV/Sales Ratio | 2.19 | 2.50 | 2.15 | 2.07 | 1.86 | 2.86 |
EV/EBITDA Ratio | 15.00 | 16.84 | 17.49 | 16.59 | 17.00 | 23.56 |
EV/EBIT Ratio | 20.54 | 22.00 | 22.65 | 21.81 | 23.94 | 30.78 |
EV/FCF Ratio | 25.36 | 29.70 | 19.15 | 11.76 | 50.77 | 37.41 |
Debt / Equity Ratio | 1.02 | 1.02 | 0.72 | 0.69 | 0.50 | 0.25 |
Debt / EBITDA Ratio | 4.69 | 4.69 | 4.06 | 4.03 | 2.75 | 1.63 |
Debt / FCF Ratio | 8.96 | 8.96 | 4.99 | 3.23 | 9.27 | 2.72 |
Net Debt / Equity Ratio | 0.20 | 0.20 | 0.12 | 0.04 | 0.14 | 0.03 |
Net Debt / EBITDA Ratio | 1.01 | 1.01 | 0.74 | 0.27 | 0.83 | 0.18 |
Net Debt / FCF Ratio | 1.78 | 1.78 | 0.82 | 0.19 | 2.48 | 0.28 |
Asset Turnover | 0.56 | 0.56 | 0.57 | 0.63 | 0.74 | 0.77 |
Inventory Turnover | 4.06 | 4.06 | 4.14 | 3.70 | 3.62 | 4.07 |
Quick Ratio | 0.75 | 0.75 | 0.95 | 0.98 | 0.74 | 0.89 |
Current Ratio | 0.94 | 0.94 | 1.20 | 1.22 | 1.12 | 1.31 |
Return on Equity (ROE) | 5.99% | 5.99% | 8.46% | 12.33% | 8.36% | 9.49% |
Return on Assets (ROA) | 3.94% | 3.94% | 3.37% | 3.72% | 3.61% | 4.44% |
Return on Invested Capital (ROIC) | 9.79% | 9.79% | 9.34% | 11.39% | 8.76% | 8.77% |
Return on Capital Employed (ROCE) | 11.30% | 11.30% | 8.70% | 8.60% | 9.00% | 10.20% |
Earnings Yield | 1.60% | 1.23% | 2.40% | 3.80% | 3.14% | 2.57% |
FCF Yield | 4.41% | 3.39% | 5.47% | 8.46% | 2.06% | 2.83% |
Dividend Yield | 2.96% | - | 2.67% | 1.74% | 2.10% | 1.55% |
Payout Ratio | 236.69% | 236.69% | 217.13% | 59.01% | 75.48% | 38.97% |
Buyback Yield / Dilution | -1.34% | -0.28% | -1.03% | -1.19% | 2.82% | -10.26% |
Total Shareholder Return | 1.67% | -0.28% | 1.64% | 0.55% | 4.92% | -8.71% |